New imaging methods for detecting diabetic retinopathy
Novel ultrahigh speed swept source OCT angiography methods in diabetic retinopathy
This study is testing a new imaging technique to help doctors spot and track diabetic retinopathy early, so patients can get the right treatment sooner and protect their vision.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-10883696 on NIH RePORTER |
What this research studies
This research focuses on developing advanced imaging techniques to detect and monitor diabetic retinopathy, a condition that can lead to blindness. By utilizing ultrahigh speed swept-source optical coherence tomography (OCT), the project aims to create detailed images of the retinal blood vessels and assess blood flow at the capillary level. This innovative approach will help in early detection of vision-threatening changes, allowing for timely treatment and better management of the disease. Patients will benefit from improved diagnostic tools that can provide objective assessments of their retinal health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with diabetes who are at risk of developing diabetic retinopathy.
Not a fit: Patients without diabetes or those who do not have any signs of diabetic retinopathy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of diabetic retinopathy, potentially preserving vision for many patients.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for retinal assessment, indicating that this approach could lead to significant advancements in diabetic retinopathy management.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Fujimoto, James G — Massachusetts Institute of Technology
- Study coordinator: Fujimoto, James G
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.